Skip to footer

Building a robust combination product strategy for patients

7 MINS READ

Harminder Arora

Segment head, Life Sciences

Ranga Kuchlyan

Client partner, Life Sciences

Highlights

  • Until recently, cancer patients had to visit clinics after chemotherapy to take a specific drug; now, it is administrated through an auto-injector at home.
  • Companies realize the need for a cohesive process for design, development, and manufacturing of their combination products.
  • One way combination products can get to market faster is by building an integrated clinical strategy for drugs and devices.